|
EPB41 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.65000000005045E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.674190E-02 |
| Normal-vs-Stage2 |
3.625900E-02 |
| Normal-vs-Stage3 |
2.460100E-02 |
| Normal-vs-Stage4 |
3.949800E-02 |
| Stage1-vs-Stage2 |
1.490030E-01 |
| Stage1-vs-Stage3 |
1.566000E-01 |
| Stage1-vs-Stage4 |
1.256390E-01 |
| Stage2-vs-Stage3 |
8.055600E-01 |
| Stage2-vs-Stage4 |
9.137000E-01 |
| Stage3-vs-Stage4 |
9.172000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.37879999999535E-05 |
| Normal-vs-AfricanAmerican |
9.995100E-03 |
| Normal-vs-Asian |
1.316200E-01 |
| Caucasian-vs-AfricanAmerican |
2.448600E-01 |
| Caucasian-vs-Asian |
1.268570E-01 |
| AfricanAmerican-vs-Asian |
2.326200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.83019999999901E-05 |
| Normal-vs-Female |
2.498000E-03 |
| Male-vs-Female |
9.604800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.076100E-02 |
| Normal-vs-Extreme_Weight |
2.963800E-02 |
| Normal-vs-Obese |
1.207890E-02 |
| Normal-vs-Extreme_Obese |
3.840300E-03 |
| Normal_Weight-vs-Extreme_Weight |
5.668400E-01 |
| Normal_Weight-vs-Obese |
9.121800E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.945800E-01 |
| Extreme_Weight-vs-Obese |
6.143000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.568600E-01 |
| Obese-vs-Extreme_Obese |
9.146200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.108000E-02 |
| Normal-vs-Age(41-60Yrs) |
1.600020E-04 |
| Normal-vs-Age(61-80Yrs) |
4.496700E-03 |
| Normal-vs-Age(81-100Yrs) |
4.092000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.001800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.971900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.925800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.094820E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.073200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.836800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.944600E-03 |
| Normal-VS-Type2 PRCC |
1.618390E-04 |
| Normal-VS-KIRP CIMP |
5.197600E-02 |
| Normal-VS-Unclassified PRCC |
5.857600E-03 |
| Type1 PRCC-VS-Type2 PRCC |
7.460200E-03 |
| Type1 PRCC-VS-KIRP CIMP |
4.192400E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
3.866800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.842000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
5.085900E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.770410E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.440900E-03 |
| Normal-vs-N1 |
2.547900E-02 |
| Normal-vs-N2 |
4.394400E-01 |
| N0-vs-N1 |
4.847800E-01 |
| N0-vs-N2 |
7.627400E-01 |
| N1-vs-N2 |
9.592400E-01 |
|
|
